Big Island Coronavirus Updates

UH Seeks Participants for COVID Treatment Study

September 20, 2020, 10:26 AM HST
Listen to this Article
1 minute
Loading Audio...
A
A
A

University of Hawai‘i logo. Wikipedia photo

The University of Hawaiʻi continues to seek participants for an ongoing coronavirus study.

UH’s John A. Burns School of Medicine (JABSOM) COVID-19 clinical trial is seeking individuals who were recently diagnosed with the virus to participate in a 21-day study. Participants will be placed on either a placebo (sugar pill) or telmisartan, a medication commonly used for blood pressure control.

The purpose of the study is to help find an effective treatment for patients with COVID-19. Researchers hope to find preliminary evidence that taking telmisartan will prevent many of the harmful effects of the virus.

Researchers will test the hypothesis that much of the dangerous lung and heart effects of COVID-19 is caused by the virus’s ability to dysregulate the delicate balance in a hormone system in the human body called the renin angiotensin system. Telmisartan lowers blood pressure by blocking the harmful effects to this hormone system.

Researchers say it is an advantage that telmisartan is already FDA-approved and many of the safety concerns of this drug are already known.

ARTICLE CONTINUES BELOW AD

A team of JABSOM researchers is behind the study, led by Cecilia Shikumuma, professor of medicine and lead investigator. Participants will be closely monitored by experienced nurses and doctors, UH said in a press release.

ARTICLE CONTINUES BELOW AD

The study is ongoing until all spots have been filled. Participants can be seen for the study right outside their homes if there is a safe place to be seen, or they can come for study visits right outside the JABSOM clinic.

Participants will be paid $40 per study visit for a total of four visits ($160).

In addition to taking medications for 21 days, participants will be asked to monitor their temperatures and blood pressures at home. The study will draw blood and obtain self-administered nasal swabs during study visits.

ARTICLE CONTINUES BELOW AD

For more information and to sign up for the study, contact Cris Milne at (808) 692-1335 or email [email protected]. Those interested may also visit the website.

Comments

This comments section is a public community forum for the purpose of free expression. Although Big Island Now encourages respectful communication only, some content may be considered offensive. Please view at your own discretion. View Comments

Newsletters

Get a quick summary of what’s happening on the Big Island with our daily & weekly email of news highlights.